1. Home
  2. FISI vs IMMX Comparison

FISI vs IMMX Comparison

Compare FISI & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Financial Institutions Inc.

FISI

Financial Institutions Inc.

HOLD

Current Price

$40.92

Market Cap

804.4M

Sector

Finance

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$14.31

Market Cap

716.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FISI
IMMX
Founded
1817
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
804.4M
716.2M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
FISI
IMMX
Price
$40.92
$14.31
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$37.00
$19.20
AVG Volume (30 Days)
130.3K
1.6M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
3.76%
N/A
EPS Growth
231.27
N/A
EPS
2.08
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.22
N/A
P/E Ratio
$19.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.61
$1.94
52 Week High
$42.97
$15.10

Technical Indicators

Market Signals
Indicator
FISI
IMMX
Relative Strength Index (RSI) 51.57 74.25
Support Level $41.00 $7.96
Resistance Level $42.97 N/A
Average True Range (ATR) 0.66 0.90
MACD -0.21 0.35
Stochastic Oscillator 44.97 89.71

Price Performance

Historical Comparison
FISI
IMMX

About FISI Financial Institutions Inc.

Financial Institutions Inc operates through its subsidiaries, providing full range of banking services to consumer, commercial and municipal customers in Western and Central New York, and commercial loans in the Mid-Atlantic region, through a loan production office in Ellicott City, Maryland. It offers a broad range of loans including commercial business and revolving lines of credit, commercial mortgages, equipment loans, residential mortgage loans and home equity loans and lines of credit, automobile loans and personal loans. It operates in single segment of Banking.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: